Gastrointestinal Bleeding Treatment Market
Gastrointestinal Bleeding Treatment Market By Product (Endoscopic Hemostatic Devices, Thermal Devices, Mechanical Devices, Closure Devices), By GI Tract Division (Upper GI Tract, Lower GI Tract), By End-users & By Regions - Global Market Insights 2020 - 2026
Analysis of Gastrointestinal Bleeding Treatment market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Gastrointestinal Bleeding Treatment Market Outlook (2020 to 2026)
Projections for global gastrointestinal bleeding treatment market indicate a moderate growth rate of 5.1% during the forecast period (2020 to 2026). The market is set to surpass a value of US$ 849.79 by the end of 2026.
New product launches with technological enhancements have further augmented the market in the past. For instance, Cook Medical’s Hemospray, an endoscopic hemostat, received FDA approval in 2018 in line with gastrointestinal bleeding treatment guidelines.
The COVID-19 pandemic is poised to burgeon production of GI bleeding treatment products. Studies have proven that the COVID-19 virus affects the gastrointestinal tract of patients, causing diarrhea, nausea and vomiting. COVID-19 is soon emerging as one of the main gastrointestinal bleeding causes.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Global Gastrointestinal Bleeding Treatment Market Trends
Endoscopic hemostasis has gained significant traction as an approach to treat GI bleeding. Established treatment modes include mechanical therapy, injection therapy and thermal therapy. The approach is well known for its ability to reduce mortality associated with GI bleeding.
Leading technological developments in development of hemostatic sprays and stents are being adopted to stop GI bleeding. This is expected to augment the gastrointestinal bleeding treatment market in the future.
Global Gastrointestinal Bleeding Treatment Market: Technological Insights:
Various technological advancements have streamlined the GI bleeding treatment market in the past few years. These include hemosprays, over-the-scope clips, padlock clips, radiofrequency ablation and self-expanding metal stents. Hemospray is a hemostatic powder developed by Cook Medical for treating gastrointestinal bleeding.
In recent years, transcatheter arterial embolization procedures have become the first-line therapy for managing upper GI bleeding that is refractory to endoscopic hemostasis. Advances in catheter-based techniques and newer embolic agents has broadened the scope of interventional radiology in managing hemorrhage. Transcatheter arterial embolization is effective for several indications. These include peptic ulcer bleeding, malignant diseases, and iatrogenic or trauma bleeding.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Global Gastrointestinal Bleeding Treatment Market: Product Insights
Endoscopic hemostatic devices are anticipated to account for more than half of the total gastrointestinal bleeding treatment market throughout the forecast period. Among these devices, the mechanical devices sub-segment is set to register maximum growth.
Increased usage of these devices for first line of treatment is a key driver behind the sub-segment’s growth. The Mechanical Devices sub-segment is set to expand at an impressive CAGR of 6.1% during the forecast period.
Global Gastrointestinal Bleeding Treatment Market: Application Insights:
Upper GI Tract bleeding is one of the most prevalent symptoms of peptic ulcers. Other causes include esophageal varices, gastric varices, hemorrhagic gastritis and Mallory-Weiss syndrome. These conditions account for nearly 250,000 hospitalizations in the U.S. and over 300,000 in the U.K.
Based on peptic ulcers treatment trends, the upper GI tract segment is projected to capture more than 70% of the global GI bleeding treatment market. The segment shall expand at a CAGR of 4.8% during the forecast period.
At the same time, lower GI tract conditions such as diverticulosis, hemorrhoids, irritable bowel syndrome, colon polyps or cancer and vascular ectasia, have increased. This increasing prevalence of lower GI tract infections is anticipated to leverage market prospects.
The lower GI tract segment is anticipated to capture nearly three-tenths of the global gastrointestinal bleeding treatment market, expanding at a CAGR of 4.0% during the forecast period.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Global Gastrointestinal Bleeding Treatment Market Regional Insights
North America is set to retain hegemony over the gastrointestinal bleeding treatment market throughout the forecast period. The increasing hospitalization rate, strong presence of market leaders and product approvals such as the approval of Hemospray, are leading drivers of the burgeoning market share. Hemospray cost is also anticipated to be competitive in this region. Analysts project North America’s market share at over two-fifth of the total GI bleeding market.
Pursuing North America is Asia-Pacific, with a projected CAGR of 6% during the forecast period. Growth in the Asia-Pacific is attributed to increase in geriatric population, rise in prevalence of GI bleeding with age, and significant product launches and strategic acquisitions by leading market players. By 2026, Asia-Pacific is expected to surpass a valuation of US$ 96.2 Mn.
Product Launches by Key Players to follow Gastrointestinal Bleeding Treatment Protocol
The global gastrointestinal bleeding treatment market is consolidated, with the presence of three major players contributing half of the total revenue. These companies are Boston Scientific Corporation, Cook Medical and Olympus Corporation.
Boston Scientific Corporation develops, markets and manufactures a wide range of products within the GI market. For instance, it manufactures Speedband Superview Super 7TM Multiple Band Ligator. This device is used for endoscopic ligation of esophageal varices and anorectal hemorrhoids.
Olympus Corporation, another market leader, concentrates on expansion of manufacturing facilities and leveraging healthcare awareness programs to stimulate early diagnosis of diseases. It focuses on reform and development activities related to medical systems across the world.
COVID-19 Market Insights:
The COVID-19 pandemic has significant ramifications for gastrointestinal bleeding treatment market. Until recently, it was hypothesized that the COVID-19 virus primarily infects respiratory epithelial cells, and is transmitted via respiratory droplets.
However, several reports generated from a study conducted in February 2020 detected SARS-CoV-2 viral RNA in stool samples. Fecal occult blood testing indicated an upper gastrointestinal bleed in one of the patients.
Before the respiratory symptoms manifested, many patients reported severe cases of diarrhea, nausea, vomiting and abdominal discomfort. Therefore, it is imperative to safeguard GI disorders patients from the COVID-19 attack.
Important GI bleeding market players have thus streamlined their production in order to meet the burgeoning needs of healthcare providers. Erbe Elektromedizin GmBh, is ensuring security of supply so as not to experience any shortage of essential medical equipment. They have introduced shift-based operations to ensure sustainable production.
On a similar plane, Cook Medical has implemented shift changes and is closely monitoring its raw material supply chain. The company produces the Instinct TM Endoscopic Hemoclip, for the purpose of endoscopic marking and hemostasis for bleeding ulcers.
Moreover, hospitals, clinics, and other healthcare settings are engaged in simple management of endoscopes, endoscope reprocessing, and storage areas for gastrointestinal treatment purposes.
These include high-level disinfection through manual cleaning, reprocessing of endoscopes by experienced staff, and meticulous room cleaning post every procedure.
Analyst’s Viewpoint:
Leading manufacturers have invested heavily in introducing technological advancements in order to broad base their market presence. Moreover, the COVID-19 pandemic outbreak shall create an upsurge in the market, owing to recent studies concluding potential infections in the GI tract.
Global Gastrointestinal Bleeding Treatment Market: Report Scope:
The recent study by Fact.MR on the global gastrointestinal bleeding treatment market provides a 6-year forecast on the key drivers, restraints and opportunities for expansion.
An in-depth analysis across various segments of the gastrointestinal bleeding treatment market has been incorporated in the report. Segmentation has been done on the basis of product, GI tract division and end-user. Each segment includes analysis based on revenue, market share and growth rate.
A detailed regional analysis has also been provided, based on the following five geographies: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Each region incorporates market analysis based on the segments highlighted above.
In addition, a section on the competitive landscape has also been provided, incorporating information on key market players, their strategies for expansion and an overview of their strengths, weaknesses, opportunities and threats.
Gastrointestinal Bleeding Treatment Market Segmentation
Fact.MR has studied the gastrointestinal bleeding treatment market with detailed segmentation on the basis of product, GI tract division, end-users and key regions.
-
By Product :
- Endoscopic Hemostatic Devices
- Thermal Devices
- Mechanical Devices
- Closure Devices
- Others
- Endoscopic Hemostatic Devices
-
By GI Tract Division :
- Upper GI Tract
- Lower GI Tract
-
By End-users :
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
-
By Key Regions :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than the addressee(s) is unauthorized and prohibited.”
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Acronyms Used 3. Research Methodology 4. Executive Summary 5. Market Overview 5.1. Product Overview 5.2. Market Dynamics 5.2.1. Drivers 5.2.1.1. Increase in geriatric population 5.2.1.2. Government and non-government funding 5.2.1.3. High prevalence of upper gastrointestinal bleeding 5.2.1.4. Rise in applications of endoscopic hemostasis 5.2.1.5. Significant product launches 5.2.1.6. Strategic acquisitions 5.2.2. Restraints 5.2.2.1. Dearth of skilled labor 5.2.2.2. Product recalls 5.2.2.3. Limitations of endoscopic management 5.2.3. Opportunities 5.2.3.1. Increase in adoption of combination therapy 5.2.3.2. Untapped emerging economies 5.3. Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, 2016?2026 5.4. Global Gastrointestinal Bleeding Treatment Market Outlook 5.5. Key Industry Developments 5.6. Technological Advancements 5.7. Disease Epidemiological Assessment 5.8. Global Incidence of Gastrointestinal Cancers by Region 5.9. Reimbursement Scenario Assessment 5.10. Strategies Adopted by Top 3 Players 5.11. Healthcare Overview 6. Global Gastrointestinal Bleeding Treatment Market Analysis, by Product 6.1. Introduction 6.2. Key Findings 6.3. Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product 6.4. Global Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2016?2026 6.4.1. Endoscopic Hemostatic Devices 6.4.1.1. Thermal Devices 6.4.1.2. Mechanical Devices 6.4.2. Closure Devices 6.4.3. Others 6.5. Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2020–2026 7. Global Gastrointestinal Bleeding Treatment Market Analysis, by GI Tract Division 7.1. Introduction 7.2. Key Findings 7.3. Market Value Share Analysis, by GI Tract Division 7.4. Market Value Forecast, by Procedure, 2020–2026 7.4.1. Upper GI Tract Division 7.4.2. Lower GI Tract Division 7.5. Market Attractiveness, by GI Tract Division 8. Global Gastrointestinal Bleeding Treatment Market Analysis, by End-user 8.1. Introduction 8.2. Key Findings 8.3. Market Value Share Analysis, by End-user 8.4. Market Value Forecast, by End-user, 2020–2026 8.4.1. Hospitals 8.4.2. Clinics 8.4.3. Ambulatory Surgical Centers 8.4.4. Others 8.5. Market Attractiveness, by End-user 9. Global Gastrointestinal Bleeding Treatment Market Analysis and Forecasts, by Region 9.1. Introduction 9.2. Regional Outlook 9.3. Global Gastrointestinal Bleeding Treatment Market Value Forecast, by Region, 2020–2026 9.3.1. North America 9.3.2. Europe 9.3.3. Asia Pacific 9.3.4. Latin America 9.3.5. Middle East & Africa 9.4. Global Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Region 10. North America Gastrointestinal Bleeding Treatment Market Analysis 10.1. Key Findings 10.2. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by Country, 2016?2026 10.2.1. U.S. 10.2.2. Canada 10.3. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2020–2026 10.3.1. Endoscopic Hemostatic Devices 10.3.1.1. Thermal Devices 10.3.1.2. Mechanical Devices 10.3.2. Closure Devices 10.3.3. Others 10.4. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2020–2026 10.4.1. Upper GI Tract 10.4.2. Lower GI Tract 10.5. North America Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2020–2026 10.5.1. Hospitals 10.5.2. Clinics 10.5.3. Ambulatory Surgical Centers 10.5.4. Others 10.6. North America Market Attractiveness Analysis 10.6.1. By Country 10.6.2. By Product 10.6.3. By GI Tract Division 10.6.4. By End-user 11. Europe Gastrointestinal Bleeding Treatment Market Analysis 11.1. Key Findings 11.2. Europe Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026 11.2.1. Germany 11.2.2. U.K. 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Rest of Europe 11.3. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2020–2026 11.3.1. Endoscopic Hemostatic Devices 11.3.1.1. Thermal Devices 11.3.1.2. Mechanical Devices 11.3.2. Closure Devices 11.3.3. Others 11.4. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2020–2026 11.4.1. Upper GI Tract 11.4.2. Lower GI Tract 11.5. Europe Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2020–2026 11.5.1. Hospitals 11.5.2. Clinics 11.5.3. Ambulatory Surgical Centers 11.5.4. Others 11.6. Europe Market Attractiveness Analysis 11.6.1. By Country/Sub-region 11.6.2. By Product 11.6.3. By GI Tract Division 11.6.4. By End-user 12. Asia Pacific Gastrointestinal Bleeding Treatment Market Analysis 12.1. Key Findings 12.2. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026 12.2.1. China 12.2.2. India 12.2.3. Japan 12.2.4. Australia 12.2.5. Rest of Asia Pacific 12.3. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2020–2026 12.3.1. Endoscopic Hemostatic Devices 12.3.1.1. Thermal Devices 12.3.1.2. Mechanical Devices 12.3.2. Closure Devices 12.3.3. Others 12.4. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2020–2026 12.4.1. Upper GI Tract 12.4.2. Lower GI Tract 12.5. Asia Pacific Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2020–2026 12.5.1. Hospitals 12.5.2. Clinics 12.5.3. Ambulatory Surgical Centers 12.5.4. Others 12.6. Asia Pacific Market Attractiveness Analysis 12.6.1. By Country/Sub-region 12.6.2. By Product 12.6.3. By GI Tract Division 12.6.4. By End-user 13. Latin America Gastrointestinal Bleeding Treatment Market Analysis 13.1. Key Findings 13.2. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026 13.2.1. Brazil 13.2.2. Mexico 13.2.3. Rest of Latin America 13.3. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2020–2026 13.3.1. Endoscopic Hemostatic Devices 13.3.1.1. Thermal Devices 13.3.1.2. Mechanical Devices 13.3.2. Closure Devices 13.3.3. Others 13.4. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2020–2026 13.4.1. Upper GI Tract 13.4.2. Lower GI Tract 13.5. Latin America Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2020–2026 13.5.1. Hospitals 13.5.2. Clinics 13.5.3. Ambulatory Surgical Centers 13.5.4. Others 13.6. Latin America Market Attractiveness Analysis 13.6.1. By Country/Sub-region 13.6.2. By Product 13.6.3. By GI Tract Division 13.6.4. By End-user 14. Middle East & Africa Gastrointestinal Bleeding Treatment Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast by Country/Sub-region, 2016?2026 14.2.1. GCC Countries 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of Middle East & Africa 14.3. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by Product, 2020–2026 14.3.1. Endoscopic Hemostatic Devices 14.3.1.1. Thermal Devices 14.3.1.2. Mechanical Devices 14.3.2. Closure Devices 14.3.3. Others 14.4. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by GI Tract Division, 2020–2026 14.4.1. Upper GI Tract 14.4.2. Lower GI Tract 14.5. Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Forecast, by End-user, 2020–2026 14.5.1. Hospitals 14.5.2. Clinics 14.5.3. Ambulatory Surgical Centers 14.5.4. Others 14.6. Middle East & Africa Market Attractiveness Analysis 14.6.1. By Country/Sub-region 14.6.2. By Product 14.6.3. By GI Tract Division 14.6.4. By End-user 15. Competitive Landscape 15.1. Competition Matrix 15.2. Gastrointestinal Bleeding Treatment Market Share Analysis, by Company, 2018 15.3. Company Profiles 15.3.1. Boston Scientific Corporation 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. SWOT Analysis 15.3.1.5. Strategic Overview 15.3.2. Olympus Corporation 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2.2. Financial Overview 15.3.2.3. Product Portfolio 15.3.2.4. SWOT Analysis 15.3.2.5. Strategic Overview 15.3.3. CONMED Corporation 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.3.2. Financial Overview 15.3.3.3. Product Portfolio 15.3.3.4. SWOT Analysis 15.3.3.5. Strategic Overview 15.3.4. Cook Medical 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.4.2. Product Portfolio 15.3.4.3. SWOT Analysis 15.3.4.4. Strategic Overview 15.3.5. Ovesco Endoscopy AG 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.5.2. Financial Overview 15.3.5.3. Product Portfolio 15.3.5.4. SWOT Analysis 15.3.5.5. Strategic Overview 15.3.6. Erbe Elektromedizin GmbH 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.6.2. Financial Overview 15.3.6.3. Product Portfolio 15.3.6.4. SWOT Analysis 15.3.6.5. Strategic Overview 15.3.7. Steris, plc 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.7.2. Financial Overview 15.3.7.3. Product Portfolio 15.3.7.4. SWOT Analysis 15.3.7.5. Strategic Overview 15.3.8. US Medical Innovations, LLC 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.8.2. Product Portfolio 15.3.8.3. SWOT Analysis
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Causes and their associate factors of Gastrointestinal Bleeding
Table 02: Global Estimates of the Number of Incidence for Gastrointestinal Cancers in Male, by Region
Table 03: Global Estimates of the Number of Incidence for Gastrointestinal Cancers in Female, by Region
Table 04: CPT Codes- Endoscopic Hemostatic Procedures – Control of Bleeding
Table 05: CPT Codes- Endoscopic Hemostatic Procedures – Ligation
Table 06: CPT Codes- Endoscopic Hemostatic Procedures – Injection
Table 07: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2020–2026
Table 08: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2020–2026
Table 09: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2020–2026
Table 10: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2020–2026
Table 11: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) Forecast, by Region, 2020–2026
Table 12: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country, 2020–2026
Table 13: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2020–2026
Table 14: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2020–2026
Table 15: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2020–2026
Table 17: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2026
Table 18: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2020–2026
Table 19: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2020–2026
Table 20: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2020–2026
Table 21: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2020–2026
Table 22: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2026
Table 23: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2020–2026
Table 24: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2020–2026
Table 25: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2020–2026
Table 26: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2020–2026
Table 27: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2026
Table 28: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2020–2026
Table 29: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2020–2026
Table 30: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2020–2026
Table 31: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2020–2026
Table 32: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020–2026
Table 33: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Product, 2020–2026
Table 34: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by Endoscopic Hemostatic Devices, 2020–2026
Table 35: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by GI Tract Division, 2020–2026
Table 36: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) Forecast, by End-user, 2020–2026
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Gastrointestinal Bleeding Treatment Market Size (US$ Mn) and Distribution, by Region, 2020 and 2026
Figure 02: Global Gastrointestinal Bleeding Treatment Market Size (US$ Mn) and Forecast, 2020–2026
Figure 03: Market Value Share, by Product, 2018
Figure 04: Market Value Share, by GI Tract Division, 2018
Figure 05: Market Value Share, by End-user, 2018
Figure 06: Market Value Share, by Region, 2018
Figure 07: Gastrointestinal Bleeding Treatment – Technological Advances
Figure 08 Causes- Upper Gastrointestinal Bleeding
Figure 09: Classification of peptic ulcers
Figure 10: Types of Lower GI Bleeding
Figure 11: Causes- Lower Gastrointestinal Bleeding
Figure 12: Top 3 Players operating in Market Space
Figure 13: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2020 and 2026
Figure 14: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Endoscopic Hemostatic Devices, 2020–2026
Figure 15: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Closure Devices, 2020–2026
Figure 16: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2020–2026
Figure 17: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Thermal Devices, 2020–2026
Figure 18: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mechanical Devices, 2020–2026
Figure 19: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2020–2026
Figure 20: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2020–2026
Figure 21: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2020 and 2026
Figure 22: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Upper GI Tract Division, 2020–2026
Figure 23: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lower GI Tract Division, 2020–2026
Figure 24: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2020–2026
Figure 25: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2020 and 2026
Figure 26: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2020–2026
Figure 27: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinics, 2020–2026
Figure 28: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ambulatory Surgical Centers, 2020–2026
Figure 29: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2020–2026
Figure 30: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2020–2026
Figure 31: Gastrointestinal Bleeding Treatment Market: Regional Outlook
Figure 32: Global Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2020–2026
Figure 33: Global Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Region, 2020 and 2026
Figure 34: Global Gastrointestinal Bleeding Treatment Market Attractiveness, by Region, 2018-2026
Figure 35: North America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2020–2026
Figure 36: North America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country, 2020–2026
Figure 37: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country, 2020 and 2026
Figure 38: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2020 and 2026
Figure 39: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2020 and 2026
Figure 40: North America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2020 and 2026
Figure 41: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2020–2026
Figure 42: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2020–2026
Figure 43: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2020–2026
Figure 44: North America Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2020–2026
Figure 45: Europe Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2020–2026
Figure 46: Europe Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2026
Figure 47: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2026
Figure 48: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2020 and 2026
Figure 49: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2020 and 2026
Figure 50: Europe Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2020 and 2026
Figure 51: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2020–2026
Figure 52: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2020–2026
Figure 53: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2020–2026
Figure 54: Europe Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2020–2026
Figure 55: Asia Pacific Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2020–2026
Figure 56: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2026
Figure 57: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2026
Figure 58: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2020 and 2026
Figure 59: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2020 and 2026
Figure 60: Asia Pacific Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2020 and 2026
Figure 61: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2020–2026
Figure 62: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2020–2026
Figure 63: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2020–2026
Figure 64: Asia Pacific Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2020–2026
Figure 65: Latin America Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2020–2026
Figure 66: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2026
Figure 67: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2026
Figure 68: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2020 and 2026
Figure 69: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2020 and 2026
Figure 70: Latin America Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2020 and 2026
Figure 71: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2020–2026
Figure 72: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2020–2026
Figure 73: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2020–2026
Figure 74: Latin America Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2020–2026
Figure 75: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2020–2026
Figure 76: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2026
Figure 77: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Country/Sub-region, 2020 and 2026
Figure 78: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by Product, 2020 and 2026
Figure 79: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by GI Tract Division, 2020 and 2026
Figure 80: Middle East & Africa Gastrointestinal Bleeding Treatment Market Value Share Analysis, by End-user, 2020 and 2026
Figure 81: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by Product, 2020–2026
Figure 82: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by Endoscopic Hemostatic Devices, 2020–2026
Figure 83: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by GI Tract Division, 2020–2026
Figure 84: Middle East & Africa Gastrointestinal Bleeding Treatment Market Attractiveness, by End-user, 2020–2026
Figure 85: Global Gastrointestinal Bleeding Treatment Market Share Analysis, by Company (2018)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the expected growth of the global gastrointestinal bleeding treatment market?
The global gastrointestinal bleeding treatment market is set to grow steadily at 5.1% during the forecast.
Which products are more popular for gastrointestinal bleeding treatment?
Endoscopic hemostasis devices has gained significant traction to treat GI bleeding, capturing more than half of the total market share.
What are the various types of technological advancements in the GI bleeding treatment?
Hemosprays, over-the-scope clips, padlock clips, radiofrequency ablation, and self-expanding metal stents are the technological advancements in GI bleeding treatment.
What growth does Asia-Pacific region expect?
Asia-Pacific region is expected to surpass a valuation of US$ 96.2 Million by 2026.
Gastrointestinal Bleeding Treatment Market